Publications by authors named "Michael A Eller"

Claim this Profile
T
The MAIT cell response to controlled oral enterotoxigenic E. coli challenge.
Kerri G Lal, Dohoon Kim, Matthew Creegan, Adam T Waickman, Jeffrey R Currier, Michael A Eller

J Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastrointestinal MAIT cells in chronic HIV-1 infection.
April L Ferre, Emily A Fehrman, Peter W Hunt, Ma Somsouk, Rebecca Hoh, Michael A Eller

J Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poxvirus Vectors Activate Human NK and MAIT Cells in a Type I Interferon, IL-18, and Monocyte-Dependent Manner.
Kombo F N'guessan, Zhanna Shubin, Kawthar Machmach, Johan K Sandberg, Julie A Ake, Michael A Eller

J Immunol Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell analyses identify monocyte gene expression profiles that influence HIV-1 reservoir size in acutely treated cohorts.
Philip K Ehrenberg, Aviva Geretz, Meta Volcic, Taisuke Izumi, Lauren K Yum, Michael A Eller

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ebola virus vaccination elicits Ebola virus-specific immune responses without substantial cross-reactivity to other filoviruses.
Thembi Mdluli, Suzanne Wollen-Roberts, Mélanie Merbah, Bradley Beckman, Yifan Li, Michael A Eller, Leigh Anne Eller

Sci Transl Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell analyses reveal that monocyte gene expression profiles influence HIV-1 reservoir size in acutely treated cohorts.
Philip K Ehrenberg, Aviva Geretz, Meta Volcic, Taisuke Izumi, Lauren Yum, Michael A Eller

bioRxiv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of Accelerated Heterologous 2-Dose Ebola Vaccine Regimens in Adults With and Without HIV in Africa.
Betty Mwesigwa, Fredrick Sawe, Janet Oyieko, Joel Mwakisisile, Edna Viegas, Leigh Anne Eller, Michael A Eller

Clin Infect Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of an Accelerated Ebola Vaccination Schedule in People with and without Human Immunodeficiency Virus: A Randomized Clinical Trial.
Julie A Ake, Kristopher Paolino, Jack N Hutter, Susan Biggs Cicatelli, Leigh Anne Eller, Michael A Eller

Vaccines (Basel)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OMIP-098: A 26 parameter, 24 color flow cytometry panel for human memory NK cell phenotyping.
Matthew Creegan, Justin Degler, Dominic Paquin-Proulx, Michael A Eller, Kawthar Machmach

Cytometry A· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Priming with Japanese encephalitis virus or yellow fever virus vaccination led to the recognition of multiple flaviviruses without boosting antibody responses induced by an inactivated Zika virus vaccine.
Yifan Li, Mélanie Merbah, Suzanne Wollen-Roberts, Bradley Beckman, Thembi Mdluli, Michael A Eller

EBioMedicine· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additional boosting to the RV144 vaccine regimen increased Fc-mediated effector function magnitude but not durability.
Zhanna Shubin, Sherry Stanfield-Oakley, Jiraporn Puangkaew, Punnee Pitisutthithum, Sorachai Nitayaphan, Michael A Eller

AIDS· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Emerging Role of MAIT Cell Responses in Viral Infections.
Johan K Sandberg, Edwin Leeansyah, Michael A Eller, Barbara L Shacklett, Dominic Paquin-Proulx

J Immunol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing the Immunogenicity of HIV Vaccines by Adjuvants - NIAID Workshop Report.
Anjali Singh, César Boggiano, Michael A Eller, Milton Maciel, Mary A Marovich

Vaccine· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALVAC-HIV and AIDSVAX B/E vaccination induce improved immune responses compared with AIDSVAX B/E vaccination alone.
Margaret C Costanzo, Dominic Paquin-Proulx, Alexandra Schuetz, Siriwat Akapirat, Zhanna Shubin, Michael A Eller

JCI Insight· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral vector delivered immunogen focuses HIV-1 antibody specificity and increases durability of the circulating antibody recall response.
LaTonya D Williams, Xiaoying Shen, Sheetal S Sawant, Siriwat Akapirat, Lindsay C Dahora, Michael A Eller

PLoS Pathog· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fc receptor engagement of HIV-1 Env-specific antibodies in mothers and infants predicts reduced vertical transmission.
Brittani M Barrows, Shelly J Krebs, Ningbo Jian, Michelle Zemil, Bonnie M Slike, Michael A Eller

Front Immunol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Susceptibility to Human Immunodeficiency Virus Type 1 Acquisition Linked to Malaria Exposure: A Case-Control Study.
Edwin Kamau, Sidhartha Chaudhury, Jessica S Bolton, Bonnie M Slike, Ningbo Jian, Michael A Eller, Leigh Anne Eller

Clin Infect Dis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissecting drivers of immune activation in chronic HIV-1 infection.
Hendrik Streeck, Alvino Maestri, Daniel Habermann, Trevor A Crowell, Allahna L Esber, Leigh Anne Eller, Michael A Eller

EBioMedicine· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Cell Profiling of Latently SIV-Infected CD4 T Cells Directly to Reveal Host Factors Supporting Reservoir Persistence.
Andrey Tokarev, Kawthar Machmach, Matthew Creegan, Dohoon Kim, Michael A Eller

Microbiol Spectr· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid CD4+ T cell infection in humans and macaques during acute HIV-1 and SHIV infection.
Vishakha Sharma, Matthew Creegan, Andrey Tokarev, Denise Hsu, Bonnie M Slike, Michael A Eller

PLoS Pathog· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report: Increased Inflammation and Liver Disease in HIV/HBV-Coinfected Individuals.
Nathanial K Copeland, Michael A Eller, Dohoon Kim, Matthew Creegan, Allahna Esber, Leigh Anne Eller

J Acquir Immune Defic Syndr· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferential and persistent impact of acute HIV-1 infection on CD4 iNKT cells in colonic mucosa.
Dominic Paquin-Proulx, Kerri G Lal, Yuwadee Phuang-Ngern, Matthew Creegan, Andrey Tokarev, Leigh Anne Eller, Michael A Eller

Proc Natl Acad Sci U S A· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations Between Antibody Fc-Mediated Effector Functions and Long-Term Sequelae in Ebola Virus Survivors.
Dominic Paquin-Proulx, Bronwyn M Gunn, Aljawharah Alrubayyi, Danielle V Clark, Matthew Creegan, Leigh Anne Eller, Michael A Eller

Front Immunol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: RV144 HIV-1 vaccination impacts post-infection antibody responses.
Thembi Mdluli, Ningbo Jian, Bonnie Slike, Dominic Paquin-Proulx, Gina Donofrio, Michael A Eller

PLoS Pathog· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidates.
Isabela Silva de Castro, Giacomo Gorini, Rosemarie Mason, Jason Gorman, Massimiliano Bissa, Michael A Eller

iScience· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis